From 29 September to 2 October, the 30th edition of the European Academy of Dermatology and Venereology (EADV) Congress was held virtually.
In a special anniversary edition, Bella Aurora, specialist in the study of melanocyte behaviour, presented their latest launch to the international scientific community in a symposium: Repigment12. The cosmetic treatment that mitigates the aesthetic consequences of vitiligo.
The symposium took place on 29 September at 11:30 and featured the presence of Dr Matteo Bordignon, specialist in the treatment of vitiligo and creator of Repigment12 alongside Bella Aurora Labs and Dr Agustín AlomarB, a Spanish dermatologist who has been studying this disease for over 30 years.
Bella Aurora Labs was represented by Marta Bajona, Medical Advisor, and took the opportunity to present a scientific poster with the results of the trial led by Dr Bordignon, proving the efficacy of the new cosmetic treatment Repigment12.
